H.R. 5343 · 119th Congress (2025–2027)
Ensuring Patient Access to Critical Breakthrough Products Act
This bill provides for Medicare coverage of medical devices that are approved under the Food and Drug Administration (FDA) Breakthrough Devices Program. (Under the program, manufacturers work with the FDA to expedite the review and approval of certain medical devices that provide for more effective treatment or diagnosis of life-threatening or irreversibly debilitating human diseases or conditions.)
The bill allows designated medical breakthrough devices to be temporarily covered under Medicare during a four-year transitional period. Manufacturers must apply to the Centers for Medicare & Medicaid Services (CMS) to receive this designation. Qualifying devices must (1) have received priority review from the FDA, (2) received premarket approval (if applicable) based on clinical data that includes data from Medicare beneficiaries, (3) already generally qualify for Medicare coverage, and (4) not present an undue risk of harm that outweighs potential clinical benefits for Medicare beneficiaries.
The CMS must approve or deny applications within six months of receipt and must provide an explanation in the case of a denial. In addition, the CMS must make permanent coverage decisions before the end of the transitional period upon a timely request to do so, as specified.
The bill provides funds through FY2030 for the CMS to implement the bill.
Show official title
To amend title XVIII of the Social Security Act to ensure prompt coverage of breakthrough devices under the Medicare program.
Ordered to be reported
Latest actionOrdered reported
This bill’s path
This is H.R. 5343’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed House
Passed Senate
Sent to President
Signed into law
- Sponsor
- Rep. Blake D. Moore (R-UT-1)
- Cosponsors
68 cosponsors
5 original · 63 later
35 R · 33 D
- Rep. Gus M. Bilirakis (R-FL-12)· Original · Sep 15, 2025
- Rep. Suzan K. DelBene (D-WA-1)· Original · Sep 15, 2025
- Rep. Terri A. Sewell (D-AL-7)· Original · Sep 15, 2025
- Rep. Lori Trahan (D-MA-3)· Original · Sep 15, 2025
- Rep. Rudy Yakym III (R-IN-2)· Original · Sep 15, 2025
- Rep. Michelle Fischbach (R-MN-7)· Later · Sep 16, 2025
- Rep. Claudia Tenney (R-NY-24)· Later · Sep 16, 2025
- Rep. Bradley Scott Schneider (D-IL-10)· Later · Sep 17, 2025
- Rep. J. Luis Correa (D-CA-46)· Later · Sep 19, 2025
- Rep. Jake Auchincloss (D-MA-4)· Later · Oct 31, 2025
- Rep. Earl L. "Buddy" Carter (R-GA-1)· Later · Oct 31, 2025
- Rep. Ted Lieu (D-CA-36)· Later · Nov 7, 2025
- Rep. Carol D. Miller (R-WV-1)· Later · Nov 7, 2025
- Rep. Ami Bera (D-CA-6)· Later · Nov 18, 2025
- Rep. Burgess Owens (R-UT-4)· Later · Nov 18, 2025
- Rep. Darren Soto (D-FL-9)· Later · Dec 2, 2025
- Rep. Randy K. Weber, Sr. (R-TX-14)· Later · Dec 2, 2025
- Rep. Jennifer A. Kiggans (R-VA-2)· Later · Dec 9, 2025
- Rep. Chris Pappas (D-NH-1)· Later · Dec 9, 2025
- Rep. Aaron Bean (R-FL-4)· Later · Dec 17, 2025
- Rep. Jimmy Panetta (D-CA-19)· Later · Jan 6, 2026
- Rep. Cliff Bentz (R-OR-2)· Later · Jan 14, 2026
- Rep. Deborah K. Ross (D-NC-2)· Later · Jan 14, 2026
- Rep. Mike Carey (R-OH-15)· Later · Feb 3, 2026
- Rep. Josh Gottheimer (D-NJ-5)· Later · Feb 3, 2026
- Rep. Michael Lawler (R-NY-17)· Later · Feb 3, 2026
- Rep. Nicole Malliotakis (R-NY-11)· Later · Feb 3, 2026
- Rep. Brittany Pettersen (D-CO-7)· Later · Feb 3, 2026
- Rep. Marilyn Strickland (D-WA-10)· Later · Feb 3, 2026
- Rep. Brian K. Fitzpatrick (R-PA-1)· Later · Feb 10, 2026
- Rep. Zoe Lofgren (D-CA-18)· Later · Feb 10, 2026
- Rep. Steve Cohen (D-TN-9)· Later · Feb 11, 2026
- Rep. Chrissy Houlahan (D-PA-6)· Later · Feb 11, 2026
- Rep. John Joyce (R-PA-13)· Later · Feb 11, 2026
- Rep. Celeste Maloy (R-UT-2)· Later · Feb 11, 2026
- Rep. Angie Craig (D-MN-2)· Later · Mar 16, 2026
- Rep. Daniel Meuser (R-PA-9)· Later · Mar 16, 2026
- Rep. David G. Valadao (R-CA-22)· Later · Apr 2, 2026
- Rep. George Whitesides (D-CA-27)· Later · Apr 2, 2026
- Rep. Brendan F. Boyle (D-PA-2)· Later · Apr 9, 2026
- Rep. Jason Crow (D-CO-6)· Later · Apr 9, 2026
- Rep. Juan Ciscomani (R-AZ-6)· Later · Apr 9, 2026
- Rep. Jay Obernolte (R-CA-23)· Later · Apr 9, 2026
- Rep. Maggie Goodlander (D-NH-2)· Later · Apr 16, 2026
- Rep. Mike Kennedy (R-UT-3)· Later · Apr 16, 2026
- Rep. Gregory F. Murphy (R-NC-3)· Later · May 14, 2026
- Rep. Kevin Mullin (D-CA-15)· Later · May 14, 2026
- Rep. Sharice Davids (D-KS-3)· Later · May 19, 2026
- Rep. David Kustoff (R-TN-8)· Later · May 19, 2026
- Rep. Sam T. Liccardo (D-CA-16)· Later · May 20, 2026
- Rep. John H. Rutherford (R-FL-5)· Later · May 20, 2026
- Rep. Nanette Diaz Barragán (D-CA-44)· Later · Jun 29, 2026
- Rep. Maria Elvira Salazar (R-FL-27)· Later · Jun 29, 2026
- Rep. Kevin Hern (R-OK-1)· Later · Jun 30, 2026
- Rep. Mike Kelly (R-PA-16)· Later · Jun 30, 2026
- Rep. Frank J. Mrvan (D-IN-1)· Later · Jun 30, 2026
- Rep. Young Kim (R-CA-40)· Later · Jul 13, 2026
- Rep. Richard McCormick (R-GA-7)· Later · Jul 13, 2026
- Rep. Scott H. Peters (D-CA-50)· Later · Jul 13, 2026
- Rep. Mary Gay Scanlon (D-PA-5)· Later · Jul 13, 2026
- Rep. Neal P. Dunn (R-FL-2)· Later · Jul 20, 2026
- Rep. Haley M. Stevens (D-MI-11)· Later · Jul 20, 2026
- Rep. Madeleine Dean (D-PA-4)· Later · Aug 3, 2026
- Rep. Thomas H. Kean, Jr. (R-NJ-7)· Later · Aug 3, 2026
- Rep. Nicholas A. Langworthy (R-NY-23)· Later · Aug 31, 2026
- Rep. Jack Bergman (R-MI-1)· Later · Oct 22, 2026
- Rep. Adrian Smith (R-NE-3)· Later · Oct 22, 2026
- Rep. Shri Thanedar (D-MI-13)· Later · Oct 22, 2026
- Policy area
- Health
- Subjects
- Congressional oversight
- Drug safety, medical device, and laboratory regulation
- Health care costs and insurance
- Health care coverage and access
- Health programs administration and funding
- Health technology, devices, supplies
- Medicare
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in House
Document: Introduced in House
Sources
- Congress.gov actionIntro-H
- Library of Congress
- Latest
▸ 3 committee actions · Sep 15, 2025 – Sep 17, 2025
Referred to committee
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sources
- Congress.gov action
- House floor actions
Markup session held
Committee Consideration and Mark-up Session Held
Sources
- Congress.gov action
- House committee actions
Ordered reported
Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 37 - 3.
Sources
- Congress.gov action
- House committee actions
Committees
Sep 17, 2025 · Markup
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in House |
Titles (2)
Ensuring Patient Access to Critical Breakthrough Products Act
Display title, Short title · Introduced in House
To amend title XVIII of the Social Security Act to ensure prompt coverage of breakthrough devices under the Medicare program.
Official title · Introduced in House